GM |
gut microbiota |
CLD |
chronic liver disease |
LC |
liver cirrhosis |
PEM |
protein-energy-malnutrition |
BCAA |
branched-chain amino acid |
HCC |
hepatocellular carcinoma |
SBP |
spontaneous bacterial peritonitis |
HE |
hepatic encephalopathy |
ACLF |
acute on chronic liver failure |
JSH |
Japanese Society of Hepatology |
CT |
computed tomography |
HCV |
hepatitis C virus |
PNALT |
persistent normal alanine aminotransferase |
COVID-19 |
Coronavirus disease-19 |
PAMPs |
pathogen-associated molecular patterns |
LPS |
lipopolysaccharide |
TLR |
toll like receptor |
NASH |
non-alcoholic steatohepatitis |
NAFLD |
non-alcoholic fatty liver disease |
HR |
hazard ratio |
CI |
confidence interval |
PPI |
proton pump inhibitor |
mTORC1 |
mammalian target of rapamycin complex1 |
TNF-α |
tumor necrosis factor-alpha |
CRC |
colorectal cancer |
SCFAs |
short-chain fatty acids |
HVPG |
hepatic venous pressure gradient |
TJ |
tight junction |
SIBO |
small intestine bacterial overgrowth |
BAs |
bile acids |
DCA |
deoxycholic acid |
RCT |
randomized controlled trial |